Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports
Conclusion The intravenous administration of paracetamol was safe and feasible in premature infants with hsPDA. Future clinical trials with optimized dose and timing of administration are needed. [...] Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Article in Thieme eJournals: Table of contents | Abstract | open access Full text
Source: American Journal of Perinatology Reports - Category: Perinatology & Neonatology Authors: Matsumura, Shun Oshima, Ayumi Fujinuma, Sumie Tanaka, Kosuke Nagano, Nobuhiko Miyake, Fuyu Masutani, Satoshi Tamura, Masanori Ueda, Keiko Namba, Fumihiko Tags: Case Report Source Type: research
More News: Clinical Trials | Gastroenterology | Indomethacin | Insurance | Japan Health | Medical Ethics | Perinatology & Neonatology